Cargando…

Icatibant, an inhibitor of bradykinin receptor 2, for hereditary angioedema attacks: prospective experimental single-cohort study

CONTEXT AND OBJECTIVE: Hereditary angioedema (HAE) with C1 inhibitor deficiency manifests as recurrent episodes of edema involving the skin, upper respiratory tract and gastrointestinal tract. It can be lethal due to asphyxia. The aim here was to evaluate the response to therapy for these attacks us...

Descripción completa

Detalles Bibliográficos
Autores principales:	Campos, Regis Albuquerque, Valle, Solange Oliveira Rodrigues, França, Alfeu Tavares, Cordeiro, Elisabete, Serpa, Faradiba Sarquis, Mello, Yara Ferreira, Malheiros, Teresinha, Toledo, Eliana, Mansour, Elie, Fusaro, Gustavo, Grumach, Anete Sevciovic
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Associação Paulista de Medicina - APM 2014
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10496749/ https://www.ncbi.nlm.nih.gov/pubmed/25054967 http://dx.doi.org/10.1590/1516-3180.2014.1325652

Ejemplares similares

Hereditary angioedema: how to approach it at the emergency department?
por: Serpa, Faradiba Sarquis, et al.
Publicado: (2021)

Therapeutic trial in hereditary angioedema type III: Icatibant
por: Garro, Laila Sabino, et al.
Publicado: (2015)

164 Treatment of Acquired Angioedema with the Bradykinin Receptor Antagonist Icatibant
por: Siani, Maria Concetta, et al.
Publicado: (2012)

Are pediatricians familiar with hereditary angioedema?
por: Chong-Neto, Herberto José, et al.
Publicado: (2023)

Hereditary angioedema: quality of life in Brazilian patients
por: Gomide, Maria Abadia Consuelo M S, et al.
Publicado: (2013)

Icatibant use in Brazilian patients with hereditary angioedema (HAE) type 1 or 2 and HAE with normal C1-INH levels: findings from the Icatibant Outcome Survey Registry Study()
por: Grumach, Anete S., et al.
Publicado: (2022)

Improvement in diagnostic delays over time in patients with hereditary angioedema: findings from the Icatibant Outcome Survey
por: Zanichelli, Andrea, et al.
Publicado: (2018)

Brazilian guidelines for the diagnosis and treatment of hereditary angioedema
por: Giavina-Bianchi, Pedro, et al.
Publicado: (2011)

Hereditary Angioedema-Associated Acute Pancreatitis in C1-Inhibitor Deficient and Normal C1-Inhibitor Patients: Case Reports and Literature Review
por: Veronez, Camila Lopes, et al.
Publicado: (2019)

Elderly versus younger patients with hereditary angioedema type I/II: patient characteristics and safety analysis from the Icatibant Outcome Survey
por: Bygum, Anette, et al.
Publicado: (2019)

Hereditary angioedema: epidemiology, management, and role of icatibant
por: Ghazi, Aasia, et al.
Publicado: (2013)

Self-administration of a novel subcutaneous bradykinin b(2) receptor antagonist, icatibant, as an effective treatment option in patients with hereditary angioedema
por: Santucci, Stephanie, et al.
Publicado: (2014)

The Icatibant Outcome Survey: treatment of laryngeal angioedema attacks
por: Longhurst, Hilary J., et al.
Publicado: (2016)

Hereditary angioedema: a disease seldom diagnosed by pediatricians
por: Campos, Régis de Albuquerque, et al.
Publicado: (2020)

Brazilian Guidelines for Hereditary Angioedema Management - 2017 Update Part 1: Definition, Classification and Diagnosis
por: Giavina-Bianchi, Pedro, et al.
Publicado: (2018)

Management of acute attacks of hereditary angioedema: potential role of icatibant
por: Longhurst, Hilary J
Publicado: (2010)

Icatibant in the Treatment of Angiotensin-Converting Enzyme Inhibitor-Induced Angioedema
por: Crooks, Neil H., et al.
Publicado: (2014)

Treatment of angiotensin-converting enzyme inhibitor related angioedema with icatibant
por: Ho, Peter, et al.
Publicado: (2014)

A novel therapeutic concept for the treatment of acute angioedema attacks in hereditary angioedema patients: multiple successful treatments even in severe swelling attacks with the bradykinin-B2 receptor antagonist Icatibant
por: Bas, M, et al.
Publicado: (2006)

Bradykinin and the Pathogenesis of Hereditary Angioedema
por: Kaplan, Allen P
Publicado: (2011)

Breakthrough attacks in patients with hereditary angioedema receiving long-term prophylaxis are responsive to icatibant: findings from the Icatibant Outcome Survey
por: Aberer, Werner, et al.
Publicado: (2017)

Continued icatibant use across recurrent attacks in adolescents with hereditary angioedema
por: Farkas, Henriette, et al.
Publicado: (2021)

Long‐term safety of icatibant treatment of patients with angioedema in real‐world clinical practice
por: Zanichelli, A., et al.
Publicado: (2017)

Comparing acquired angioedema with hereditary angioedema (types I/II): findings from the Icatibant Outcome Survey
por: Longhurst, H. J., et al.
Publicado: (2017)

165 Early Versus Delayed Treatment of Swelling Attacks with Icatibant, a Bradykinin 2 Receptor Antagonist in Patients With Hereditary Angioedema due to C1-INH Deficiency
por: Bork, Konrad, et al.
Publicado: (2012)

Bradykinin-induced angioedema in the emergency department
por: Hébert, Jacques, et al.
Publicado: (2022)

Pathophysiology of bradykinin and histamine mediated angioedema
por: Lima, Hermenio, et al.
Publicado: (2023)

Bradykinin Metabolism and Drug-Induced Angioedema
por: Smolinska, Sylwia, et al.
Publicado: (2023)

Inborn Errors of Immunity: how to diagnose them?
por: Grumach, Anete Sevciovic, et al.
Publicado: (2021)

Case report of treatment with Icatibant for recurrent throat swelling due to hereditary angioedema
por: Chung, Arthur G, et al.
Publicado: (2010)

Hereditary Angioedema Attacks Resolve Faster and Are Shorter after Early Icatibant Treatment
por: Maurer, Marcus, et al.
Publicado: (2013)

Analysis of icatibant for the treatment of laryngeal hereditary angioedema attacks in the FAST-3 study
por: Yang, William, et al.
Publicado: (2014)

Effectiveness of icatibant for treatment of hereditary angioedema attacks is not affected by body weight: findings from the Icatibant Outcome Survey, a cohort observational study
por: Caballero, Teresa, et al.
Publicado: (2018)

Expert perspectives on hereditary angioedema: Key areas for advancements in care across the patient journey
por: Banerji, Aleena, et al.
Publicado: (2016)

Angioedema Without Wheals: Challenges in Laboratorial Diagnosis
por: Grumach, Anete S., et al.
Publicado: (2021)

Enzymatic Assays for the Diagnosis of Bradykinin-Dependent Angioedema
por: Defendi, Federica, et al.
Publicado: (2013)

In Vitro Modeling of Bradykinin-Mediated Angioedema States
por: Marceau, François, et al.
Publicado: (2020)

Management of patients with hereditary angioedema in Germany: comparison with other countries in the Icatibant Outcome Survey
por: Maurer, M., et al.
Publicado: (2018)

The Icatibant Outcome Survey: experience of hereditary angioedema management from six European countries
por: Caballero, T., et al.
Publicado: (2017)

Population Pharmacokinetics and Exposure‐Response Analyses to Guide Dosing of Icatibant in Pediatric Patients With Hereditary Angioedema
por: Wang, Yi, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_bnuuc1n1eopjaccbumtcmka359